We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




First-of-Its-Kind Technology Detects ‘Invisible’ Risk of Heart Disease from Routine Cardiac CT Scans

By MedImaging International staff writers
Posted on 14 Jul 2023
Print article
Image: CaRi-Heart technology raises the bar for CAD management by quantifying both coronary inflammation and plaque (Photo courtesy of Caristo Diagnostics)
Image: CaRi-Heart technology raises the bar for CAD management by quantifying both coronary inflammation and plaque (Photo courtesy of Caristo Diagnostics)

Coronary Artery Disease (CAD), the leading cause of death globally, often remains undetected until it's too late. For many years, cardiologists have understood that inflammation is a key factor driving the onset of CAD and plaque rupture. However, existing diagnostic tests do not reliably detect it. Now, a cutting-edge image analysis technology can identify and measure the invisible signs of inflammation in routine CT heart scans.

Caristo Diagnostics’ (Oxford, UK) CaRi-Heart technology can detect coronary inflammation as well as atherosclerosis (plaque) using standard cardiac CT scans. The CaRi-Heart report quantifies coronary inflammation through a unique and patented biomarker called the Fat Attenuation Index Score (FAI Score), which is specific to each patient and measured for each coronary artery. Additionally, the CaRi-Heart report provides the CaRi-Heart Risk, which evaluates the overall eight-year risk of a fatal heart attack (based on coronary inflammation status, plaque, and clinical risk factors). Research studies have demonstrated that abnormal FAI is linked to a 6-9 times higher risk for fatal heart attacks and a 5 times higher risk for non-fatal heart attacks.

CaRi-Heart's newest product feature, the CaRi-Plaque module, is a web-based software medical device designed for trained operators to analyze cardiac computed tomography angiography (CCTA) data for the characterization and quantification of coronary plaque components. Trained operators can use the CaRi-Plaque module to generate a report describing the physical characteristics of coronary plaque powered by artificial intelligence (AI) algorithms. By combining proprietary measurements of coronary artery inflammation and plaque characteristics, with other clinical risk factors, CaRi-Heart can accurately predict an individual’s risk of heart attack to guide therapy.

"Inflammation plays an important part in the development of atherosclerosis and is a strong predictor of cardiovascular disease progression and events," said Professor Keith Channon, Caristo Diagnostics Chief Medical Officer, "Previously, chest pain clinics have returned most patients back to primary care without a defined prevention or treatment pathway. With coronary inflammation and plaque evaluation provided by the CaRi-Heart analysis, the clinical team will be able to use the additional information to identify at-risk patients more effectively and optimize their treatment, so future cardiac events can be prevented."

Related Links:
Caristo Diagnostics 

Gold Supplier
128 Slice CT Scanner
Supria 128
New
Gold Supplier
IMRT Thorax Phantom
CIRS Model 002LFC
New
Radiotherapy Software
Node Platform
New
Bladder Scanner
Z5 Bladder Scanner

Print article
Sun Nuclear -    Mirion

Channels

Radiography

view channel
Image: The AI model improves tumor removal accuracy during breast cancer surgery (Photo courtesy of UNC School of Medicine)

AI Model Analyzes Tumors Removed Surgically in Real-Time

During breast cancer surgery, the surgeon removes the tumor, also known as a specimen, along with a bit of the adjacent healthy tissue to ensure all cancerous cells are excised. This specimen is then X-rayed... Read more

MRI

view channel
Image: MRI screen-detected breast cancers have been found to be most often invasive cancers (Photo courtesy of 123RF)

MRI Screen-Detected Breast Cancers Are Mostly Invasive

Annual breast MRI screening is advised for patients with a lifetime breast cancer risk exceeding 20%. There exists robust data about the features of mammographic screen-detected breast cancers, although... Read more

Ultrasound

view channel
Image: FloPatch is a revolutionary tool that facilitates real-time precision in IV fluid management in sepsis (Photo courtesy of Flosonics)

Wireless, Wearable Doppler Ultrasound Revolutionizes Precision Fluid Management in Sepsis Care

When a patient comes to the hospital with sepsis, administering intravenous (IV) fluids is usually the first course of action. However, too much IV fluid can do more harm than good, causing additional... Read more

Nuclear Medicine

view channel
Image: An AI model can evaluate brain tumors on PET (Photo courtesy of Freepik)

AI Model for PET Imaging Determines Patient Response to Brain Tumor Treatments

The assessment of changes in metabolic tumor volume (MTV) through PET scans using specific radiotracers like F-18 fluoroethyl tyrosine (FET) plays a vital role in evaluating the treatment response in patients... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.